Lot 1
No lot description published.
The Royal United Hospitals NHS Foundation Trust is exploring options to expand its Radiopharmacy Services to improve access to diagnostics, innovative treatment and research in Southwest England. Uniquely positioned on the M4/M5 corridor, the Trust has a state-of-the-art Pharmacy build intended to provide a comprehensive range of services including: 1. Cytotoxics (191 sq ft): mainly production of systemic anticancer therapy (SACT) and clinical trials for Onc/Haem 2. Monoclonal antibodies (180 sq ft): products for Biologics unit and chemo unit 3. Radiopharmacy unit (279sq ft): supply for Nuclear medicine diagnostics & treatment 4. Vacant clean room space originally intended for Gene Therapy (108 sq ft) As part of this appraisal, the Trust is evaluating a range of potential delivery and funding models, including the possibility of a Joint Venture or other form of partnership with a private sector organisation. The purpose of this soft market testing exercise is to gain insight into: • The level of interest from suppliers and investors in collaborating with the Trust • The range of commercial, technical and operational models available within the market • Key risks, dependencies and potential mitigation approaches • Options that best ensure service continuity • Indicative timelines and delivery pathways This exercise is being undertaken for information gathering purposes only and does not constitute a call for competition or form part of any formal procurement process. The responses received will be used to inform the Trust’s approach and any potential future procurement activity. Please note, Royal United Hospitals Bath NHS Foundation Trust reserves the right not to proceed with the procurement once this Pre-Engagement stage has been finalised.
No lot description published.
| Item | Category | Quantity |
|---|---|---|
| 1 | Pharmacy services, Radio-isotopes, Pharmaceutical products, Various medicinal products, Radioactive materials | Not published |
Benchmarked against retained Find a Tender procedures with CPV division 09. The category anchor is Radioactive materials (09343000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.
| Comparison set | Procedures | Reported bids per procedure | Named award suppliers | Price evidence |
|---|---|---|---|---|
| Market: CPV division 09 | 1,838 | 4 median · 34.4 average (667 of 1,838 with a bid count) | 5 average (769 of 1,838 with named award suppliers) | Not published |
| Same buyer | 0 | Not published | Not published | Not published |
“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.
Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.
| Milestone | Type | Due | Status |
|---|---|---|---|
| Engagement with interested suppliers will be conducted on a one-to-one basis during the week commencing 15th and 22nd June. This will include an invite to a face-to-face meeting, along with an opportunity to visit and tour the Aseptic Unit. Interested parties are invited to express their interest via the Health service Family portal - https://atamis-1928.my.site.com/s/Welcome Please include a brief overview of your organisation, relevant experience and strategic ambition in Radiopharmaceutical supply services. | engagement | 30 Jun 2026 | scheduled |
No linked framework, prior procurement or reprocurement published.
Diagnostic view. “Not published” means this current release does not provide a value.
| OCID | ocds-h6vhtk-06a701 |
|---|---|
| Latest release ID | 050047-2026 |
| Latest release timestamp | Thu May 28 2026 08:22:35 GMT+0000 (Coordinated Universal Time) |
| Source | find-a-tender |
| Official notice URL | Not published |
| Tender status | planning |
| Procurement method | Not published |
| Procurement method details | Not published |
| Main procurement category | services |
| Above threshold | Yes |
| Legal basis | 2023/54 |
| Tender period: start | Not published |
| Tender period: end | Not published |
| Expression of interest deadline | Not published |
| Enquiry deadline | Not published |
| Award period: start | Not published |
| Award period: end | Not published |
| Submission method details | Not published |
| Submission languages | Not published |
| Electronic catalogue policy | Not published |
| Total tender value | Not published |
| Tender lots in source | 1 |
| Tender items in source | 1 |
| Tender documents in source | 0 |
| Awards in latest release | 0 |
| Contracts in latest release | 0 |
| Parties in latest release | 1 |
| Date | Event | Reference |
|---|---|---|
| 28 May 2026 | planningUpdate | 050047-2026 |
| 28 May 2026 | planning | 050038-2026 |
Unmodified official OCDS data retained by Tenderline for this procurement process.
{
"id": "050047-2026",
"tag": [
"planningUpdate"
],
"date": "2026-05-28T09:22:35+01:00",
"ocid": "ocds-h6vhtk-06a701",
"buyer": {
"id": "GB-PPON-PXRL-3879-BBGR",
"name": "Royal United Hospitals Bath NHS Foundation Trust"
},
"tender": {
"id": "C449972",
"lots": [
{
"id": "1",
"status": "planning",
"contractPeriod": {
"endDate": "2037-06-01T23:59:59+01:00",
"startDate": "2027-01-01T00:00:00Z"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"additionalClassifications": [
{
"id": "85149000",
"scheme": "CPV",
"description": "Pharmacy services"
},
{
"id": "09344000",
"scheme": "CPV",
"description": "Radio-isotopes"
},
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
{
"id": "33690000",
"scheme": "CPV",
"description": "Various medicinal products"
},
{
"id": "09343000",
"scheme": "CPV",
"description": "Radioactive materials"
}
]
}
],
"title": "Soft Market Testing Radiopharmacy Services Joint Venture",
"status": "planning",
"amendments": [
{
"id": "050047-2026",
"description": "Adding of Portal link"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "The Royal United Hospitals NHS Foundation Trust is exploring options to expand its Radiopharmacy Services to improve access to diagnostics, innovative treatment and research in Southwest England. \nUniquely positioned on the M4/M5 corridor, the Trust has a state-of-the-art Pharmacy build intended to provide a comprehensive range of services including:\n1. Cytotoxics (191 sq ft): mainly production of systemic anticancer therapy (SACT) and clinical trials for Onc/Haem\n2. Monoclonal antibodies (180 sq ft): products for Biologics unit and chemo unit\n3. Radiopharmacy unit (279sq ft): supply for Nuclear medicine diagnostics & treatment\n4. Vacant clean room space originally intended for Gene Therapy (108 sq ft) \nAs part of this appraisal, the Trust is evaluating a range of potential delivery and funding models, including the possibility of a Joint Venture or other form of partnership with a private sector organisation.\nThe purpose of this soft market testing exercise is to gain insight into:\n• The level of interest from suppliers and investors in collaborating with the Trust\n• The range of commercial, technical and operational models available within the market \n• Key risks, dependencies and potential mitigation approaches\n• Options that best ensure service continuity \n• Indicative timelines and delivery pathways \nThis exercise is being undertaken for information gathering purposes only and does not constitute a call for competition or form part of any formal procurement process. The responses received will be used to inform the Trust’s approach and any potential future procurement activity.\nPlease note, Royal United Hospitals Bath NHS Foundation Trust reserves the right not to proceed with the procurement once this Pre-Engagement stage has been finalised.",
"aboveThreshold": true,
"mainProcurementCategory": "services"
},
"parties": [
{
"id": "GB-PPON-PXRL-3879-BBGR",
"name": "Royal United Hospitals Bath NHS Foundation Trust",
"roles": [
"buyer"
],
"address": {
"region": "UKK12",
"country": "GB",
"locality": "Bath",
"postalCode": "BA1 3NG",
"countryName": "United Kingdom",
"streetAddress": "Procurement Team, E9 Mezzanine, Combe Park"
},
"details": {
"url": "https://www.ruh.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PXRL-3879-BBGR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "henry.prudden@nhs.net",
"telephone": "01722336262"
}
}
],
"language": "en",
"planning": {
"documents": [
{
"id": "050047-2026",
"url": "https://www.find-tender.service.gov.uk/Notice/050047-2026",
"format": "text/html",
"noticeType": "UK2",
"description": "Preliminary market engagement notice on Find a Tender",
"documentType": "marketEngagementNotice",
"datePublished": "2026-05-28T09:22:35+01:00"
}
],
"milestones": [
{
"id": "engagement",
"type": "engagement",
"status": "scheduled",
"dueDate": "2026-06-30T23:59:59+01:00",
"description": "Engagement with interested suppliers will be conducted on a one-to-one basis during the week commencing 15th and 22nd June. This will include an invite to a face-to-face meeting, along with an opportunity to visit and tour the Aseptic Unit.\nInterested parties are invited to express their interest via the Health service Family portal - https://atamis-1928.my.site.com/s/Welcome \nPlease include a brief overview of your organisation, relevant experience and strategic ambition in Radiopharmaceutical supply services."
}
]
},
"initiationType": "tender"
}{
"id": "050047-2026",
"tag": [
"planningUpdate"
],
"date": "2026-05-28T09:22:35+01:00",
"ocid": "ocds-h6vhtk-06a701",
"buyer": {
"id": "GB-PPON-PXRL-3879-BBGR",
"name": "Royal United Hospitals Bath NHS Foundation Trust"
},
"tender": {
"id": "C449972",
"lots": [
{
"id": "1",
"status": "planning",
"contractPeriod": {
"endDate": "2037-06-01T23:59:59+01:00",
"startDate": "2027-01-01T00:00:00Z"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"additionalClassifications": [
{
"id": "85149000",
"scheme": "CPV",
"description": "Pharmacy services"
},
{
"id": "09344000",
"scheme": "CPV",
"description": "Radio-isotopes"
},
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
{
"id": "33690000",
"scheme": "CPV",
"description": "Various medicinal products"
},
{
"id": "09343000",
"scheme": "CPV",
"description": "Radioactive materials"
}
]
}
],
"title": "Soft Market Testing Radiopharmacy Services Joint Venture",
"status": "planning",
"amendments": [
{
"id": "050047-2026",
"description": "Adding of Portal link"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "The Royal United Hospitals NHS Foundation Trust is exploring options to expand its Radiopharmacy Services to improve access to diagnostics, innovative treatment and research in Southwest England. \nUniquely positioned on the M4/M5 corridor, the Trust has a state-of-the-art Pharmacy build intended to provide a comprehensive range of services including:\n1. Cytotoxics (191 sq ft): mainly production of systemic anticancer therapy (SACT) and clinical trials for Onc/Haem\n2. Monoclonal antibodies (180 sq ft): products for Biologics unit and chemo unit\n3. Radiopharmacy unit (279sq ft): supply for Nuclear medicine diagnostics & treatment\n4. Vacant clean room space originally intended for Gene Therapy (108 sq ft) \nAs part of this appraisal, the Trust is evaluating a range of potential delivery and funding models, including the possibility of a Joint Venture or other form of partnership with a private sector organisation.\nThe purpose of this soft market testing exercise is to gain insight into:\n• The level of interest from suppliers and investors in collaborating with the Trust\n• The range of commercial, technical and operational models available within the market \n• Key risks, dependencies and potential mitigation approaches\n• Options that best ensure service continuity \n• Indicative timelines and delivery pathways \nThis exercise is being undertaken for information gathering purposes only and does not constitute a call for competition or form part of any formal procurement process. The responses received will be used to inform the Trust’s approach and any potential future procurement activity.\nPlease note, Royal United Hospitals Bath NHS Foundation Trust reserves the right not to proceed with the procurement once this Pre-Engagement stage has been finalised.",
"aboveThreshold": true,
"mainProcurementCategory": "services"
},
"parties": [
{
"id": "GB-PPON-PXRL-3879-BBGR",
"name": "Royal United Hospitals Bath NHS Foundation Trust",
"roles": [
"buyer"
],
"address": {
"region": "UKK12",
"country": "GB",
"locality": "Bath",
"postalCode": "BA1 3NG",
"countryName": "United Kingdom",
"streetAddress": "Procurement Team, E9 Mezzanine, Combe Park"
},
"details": {
"url": "https://www.ruh.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PXRL-3879-BBGR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "henry.prudden@nhs.net",
"telephone": "01722336262"
}
}
],
"language": "en",
"planning": {
"documents": [
{
"id": "050047-2026",
"url": "https://www.find-tender.service.gov.uk/Notice/050047-2026",
"format": "text/html",
"noticeType": "UK2",
"description": "Preliminary market engagement notice on Find a Tender",
"documentType": "marketEngagementNotice",
"datePublished": "2026-05-28T09:22:35+01:00"
}
],
"milestones": [
{
"id": "engagement",
"type": "engagement",
"status": "scheduled",
"dueDate": "2026-06-30T23:59:59+01:00",
"description": "Engagement with interested suppliers will be conducted on a one-to-one basis during the week commencing 15th and 22nd June. This will include an invite to a face-to-face meeting, along with an opportunity to visit and tour the Aseptic Unit.\nInterested parties are invited to express their interest via the Health service Family portal - https://atamis-1928.my.site.com/s/Welcome \nPlease include a brief overview of your organisation, relevant experience and strategic ambition in Radiopharmaceutical supply services."
}
]
},
"initiationType": "tender"
}{
"id": "050038-2026",
"tag": [
"planning"
],
"date": "2026-05-28T09:17:55+01:00",
"ocid": "ocds-h6vhtk-06a701",
"buyer": {
"id": "GB-PPON-PXRL-3879-BBGR",
"name": "Royal United Hospitals Bath NHS Foundation Trust"
},
"tender": {
"id": "C449972",
"lots": [
{
"id": "1",
"status": "planning",
"contractPeriod": {
"endDate": "2037-06-01T23:59:59+01:00",
"startDate": "2027-01-01T00:00:00Z"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"additionalClassifications": [
{
"id": "85149000",
"scheme": "CPV",
"description": "Pharmacy services"
},
{
"id": "09344000",
"scheme": "CPV",
"description": "Radio-isotopes"
},
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
{
"id": "33690000",
"scheme": "CPV",
"description": "Various medicinal products"
},
{
"id": "09343000",
"scheme": "CPV",
"description": "Radioactive materials"
}
]
}
],
"title": "Soft Market Testing Radiopharmacy Services Joint Venture",
"status": "planning",
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "The Royal United Hospitals NHS Foundation Trust is exploring options to expand its Radiopharmacy Services to improve access to diagnostics, innovative treatment and research in Southwest England. \nUniquely positioned on the M4/M5 corridor, the Trust has a state-of-the-art Pharmacy build intended to provide a comprehensive range of services including:\n1. Cytotoxics (191 sq ft): mainly production of systemic anticancer therapy (SACT) and clinical trials for Onc/Haem\n2. Monoclonal antibodies (180 sq ft): products for Biologics unit and chemo unit\n3. Radiopharmacy unit (279sq ft): supply for Nuclear medicine diagnostics & treatment\n4. Vacant clean room space originally intended for Gene Therapy (108 sq ft) \nAs part of this appraisal, the Trust is evaluating a range of potential delivery and funding models, including the possibility of a Joint Venture or other form of partnership with a private sector organisation.\nThe purpose of this soft market testing exercise is to gain insight into:\n• The level of interest from suppliers and investors in collaborating with the Trust\n• The range of commercial, technical and operational models available within the market \n• Key risks, dependencies and potential mitigation approaches\n• Options that best ensure service continuity \n• Indicative timelines and delivery pathways \nThis exercise is being undertaken for information gathering purposes only and does not constitute a call for competition or form part of any formal procurement process. The responses received will be used to inform the Trust’s approach and any potential future procurement activity.\nPlease note, Royal United Hospitals Bath NHS Foundation Trust reserves the right not to proceed with the procurement once this Pre-Engagement stage has been finalised.",
"aboveThreshold": true,
"mainProcurementCategory": "services"
},
"parties": [
{
"id": "GB-PPON-PXRL-3879-BBGR",
"name": "Royal United Hospitals Bath NHS Foundation Trust",
"roles": [
"buyer"
],
"address": {
"region": "UKK12",
"country": "GB",
"locality": "Bath",
"postalCode": "BA1 3NG",
"countryName": "United Kingdom",
"streetAddress": "Procurement Team, E9 Mezzanine, Combe Park"
},
"details": {
"url": "https://www.ruh.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
},
"identifier": {
"id": "PXRL-3879-BBGR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "henry.prudden@nhs.net",
"telephone": "01722336262"
}
}
],
"language": "en",
"planning": {
"documents": [
{
"id": "050038-2026",
"url": "https://www.find-tender.service.gov.uk/Notice/050038-2026",
"format": "text/html",
"noticeType": "UK2",
"description": "Preliminary market engagement notice on Find a Tender",
"documentType": "marketEngagementNotice",
"datePublished": "2026-05-28T09:17:55+01:00"
}
],
"milestones": [
{
"id": "engagement",
"type": "engagement",
"status": "scheduled",
"dueDate": "2026-06-30T23:59:59+01:00",
"description": "Engagement with interested suppliers will be conducted on a one-to-one basis during the week commencing 15th and 22nd June. This will include an invite to a face-to-face meeting, along with an opportunity to visit and tour the Aseptic Unit.\nInterested parties are invited to express their interest via the Health service Family portal. \nPlease include a brief overview of your organisation, relevant experience and strategic ambition in Radiopharmaceutical supply services."
}
]
},
"initiationType": "tender"
}